Collectively, the present results support a coherent mechanistic framework linking hypoxia, HIF-1α stabilization, and TRPV1-mediated Ca2+ dynamics, with direct implications for therapeutic targeting in estrogen-responsive cancers. Here, TRPV1 is linked to cancer.